-
Alembic Pharma Sees 4% Revenue Growth INR 138 Crore Profit in Q3FY25
3rd February 2025, Mumbai: Alembic Pharmaceuticals Limited reported its consolidated financial results for the third quarter ended 31st December, 2024. Financial Highlights  Net Sales increased by 4% to Rs.1693 Crores.  EBITDA up 1% to Rs. 271 Crores  EBITDA Margin at 16% of Sales  Net Profit at Rs.138 Crores Mr. Shaunak Amin, MD, Alembic Pharmaceuticals Limited
Search
About
At NexGen Consulting, we specialize in strategic media planning that helps brands secure the best possible coverage—across both digital and print media. With a focus on visibility, credibility, and audience engagement, we ensure your message reaches the right people, at the right time, through the right platforms.
As a results-driven media consulting agency, we work closely with businesses, startups, and professionals to build strong media presence and brand authority. Whether you need features in top publications, digital news coverage, influencer reach, or targeted content placement, our team ensures maximum impact with smart, data-backed planning.
Archive
Categories
Recent Posts
- Telangana’s Biggest Juice-Line Manufacturing Facility Inaugurated in Hyderabad
- Pravasi Bharatiya Sangeet & Nritya Mahotsav 2026 to Celebrate Global Indian Classical Arts in Kolkata
- AD Ports Group Signs AED 840 Million Land Sale Agreement with Danube Properties
- Jaro Education and Delhi Technological University announceda collaboration to launch industry-focused online degree programs and strengthen workforce upskilling
- Sri Vidhya Nilayam, Wins ‘Spirit of Mylapore’ Award 2026 from Sundaram Finance
Gallery







